Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors - Odessa American -BoardProspects

Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors

Odessa American Oct 8 2020 BoardMoves

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the appointment of Mark Litton, PhD, MBA, Chief Operating Officer of Athira Pharma (NASDAQ: ATHA), to the company's Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Incyte Names New Member to Its Board of Directors also published in Odessa American
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors also published in Odessa American
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- Board of directors
- Board
- Nasdaq
- MBA
- Mark Litton